Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) [Coronary Interventions]

Conclusions— This study showed that in most cases, the side branch ostial area free from struts initially decreased. However, with full scaffold bioresorption, the ostial area free from scaffold increased between 2 to 3 years and 5 years in the vast majority of patients. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00856856.

http://circinterventions.ahajournals.org/cgi/content/short/10/9/e004393?rss=1

Source: Circulation: Cardiovascular Interventions - September 11, 2017 Category: Cardiology Authors: Onuma, Y., Grundeken, M. J., Nakatani, S., Asano, T., Sotomi, Y., Foin, N., Ng, J., Okamura, T., Wykrzykowska, J. J., de Winter, R. J., van Geuns, R.-J., Koolen, J., Christiansen, E., Whitbourn, R., McClean, D., Smits, P., Windecker, S., Ormiston, J. A., Tags: Optical Coherence Tomography (OCT), Percutaneous Coronary Intervention, Stent Coronary Interventions Source Type: research